Ultrasound opens brain barrier to supercharge immune attack on deadly tumor

This early-stage trial tests a new treatment for a fast-growing brain cancer called glioblastoma. It combines special immune cells (EGFR BATs) with low-intensity focused ultrasound to temporarily open the blood-brain barrier, allowing more treatment to reach the tumor. The study involves 12 adults with a specific type of glioblastoma that has not responded to standard therapy. The main goals are to check safety and see if the treatment can get into the brain.